BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ochoa-Hein E, Rajme-López S, Rodríguez-Aldama JC, Huertas-Jiménez MA, Chávez-Ríos AR, de Paz-García R, Haro-Osnaya A, González-Colín KK, González-González R, González-Lara MF, Ponce-de-León A, Galindo-Fraga A. Substantial reduction of healthcare facility-onset Clostridioides difficile infection (HO-CDI) rates after conversion of a hospital for exclusive treatment of COVID-19 patients. Am J Infect Control 2021;49:966-8. [PMID: 33352250 DOI: 10.1016/j.ajic.2020.12.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Spigaglia P. Clostridioides difficile infection (CDI) during the COVID-19 pandemic. Anaerobe 2022. [DOI: 10.1016/j.anaerobe.2022.102518] [Reference Citation Analysis]
2 Merchante N, Chico P, Márquez-saavedra E, Riera G, Herrero R, González-de-la-aleja P, Aller AI, Rodríguez JC, Rodríguez-fernández M, Ramos JM, Trigo-rodríguez M, Merino E. Impact of COVID19 pandemic on the incidence of health-care associated Clostridioides difficile infection. Anaerobe 2022. [DOI: 10.1016/j.anaerobe.2022.102579] [Reference Citation Analysis]
3 Bogdanová K, Doubravská L, Vágnerová I, Hricová K, Pudová V, Röderová M, Papajk J, Uvízl R, Langová K, Kolář M. Clostridioides difficile and Vancomycin-Resistant Enterococci in COVID-19 Patients with Severe Pneumonia. Life (Basel) 2021;11:1127. [PMID: 34833003 DOI: 10.3390/life11111127] [Reference Citation Analysis]
4 Sipos S, Vlad C, Prejbeanu R, Haragus H, Vlad D, Cristian H, Dumitrascu C, Popescu R, Dumitrascu V, Predescu V. Impact of COVID-19 prevention measures on Clostridioides difficile infections in a regional acute care hospital. Exp Ther Med 2021;22:1215. [PMID: 34584560 DOI: 10.3892/etm.2021.10649] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Kullar R, Johnson S, McFarland LV, Goldstein EJC. Potential Roles for Probiotics in the Treatment of COVID-19 Patients and Prevention of Complications Associated with Increased Antibiotic Use. Antibiotics (Basel) 2021;10:408. [PMID: 33918619 DOI: 10.3390/antibiotics10040408] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Voicu MN, Popescu F, Florescu DN, Rogoveanu I, Turcu-Stiolica A, Gheonea DI, Iovanescu VF, Iordache S, Cazacu SM, Ungureanu BS. Clostridioides difficile Infection among Cirrhotic Patients with Variceal Bleeding. Antibiotics (Basel) 2021;10:731. [PMID: 34204307 DOI: 10.3390/antibiotics10060731] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Granata G, Petrosillo N, Al Moghazi S, Caraffa E, Puro V, Tillotson G, Cataldo MA. The burden of Clostridioides difficile infection in COVID-19 patients: A systematic review and meta-analysis. Anaerobe 2021;:102484. [PMID: 34843959 DOI: 10.1016/j.anaerobe.2021.102484] [Reference Citation Analysis]